A nurse prepares a dose of the Pfizer-BioNtech COVID-19 vaccine. Photo by Debbie Hill/UPI | License Photo
Sept. 22 (UPI) -- A Centers for Disease Control and Prevention committee met Wednesday to consider a possible recommendation of a third dose of the Pfizer-BioNTech COVID-19 vaccine.
The advisory panel was expected to discuss the issue over the course of 10 hours Wednesday
The CDC Advisory Committee on Immunization Practices meeting comes several days after a similar advisory panel at the Food and Drug Administration recommended a Pfizer booster shot only for those over age 65, healthcare workers and people at risk for occupational exposure to the virus.
If the full FDA grants approval for the booster doses, the CDC panel could vote on a possible recommendation Thursday.
The FDA's Vaccines and Related Biological Products Advisory Committee's vote Friday derailed the Biden administration's plans to begin offering booster shots to nearly everyone this week.
Last week, a group of FDA scientists said a third dose of Pfizer's vaccine likely increases antibodies in recipients and offers greater protection against COVID-19. However, they stopped short of saying the extra dose is needed by a majority of Americans. They said even with waning immunity over time, the two-shot regime of the Pfizer vaccine still largely protects against severe cases of COVID-19.